IBB
iShares Biotechnology ETF
1W: +0.6%
1M: -5.7%
3M: -3.9%
YTD: -2.1%
1Y: +24.6%
3Y: +32.3%
5Y: +7.5%
$165.26
-0.49 (-0.30%)
After Hours: $165.19 (-0.06, -0.04%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$7.9B
Holdings246
Top 10 Wt50.1%
Beta0.98
% Profitable17%
Coverage100%
Portfolio Valuation
P/E24.6
P/B6.5
P/S6.2
EV/EBITDA16.0
P/FCF23.9
PEG2.12
Profitability & Returns
Gross Margin83.7%
Net Margin23.0%
ROE26.0%
ROA10.0%
ROIC17.1%
Div Yield0.51%
Leverage & Liquidity
Debt/Equity0.96
Debt/Assets0.38
Net Debt/EBITDA1.1x
Interest Cov8.1x
Current Ratio1.87
Quick Ratio1.55
Growth (YoY)
Revenue+31.2%
Net Income+65.3%
EPS+69.4%
FCF+41.2%
EBITDA+66.5%
Rev CAGR 3Y+31.6%
Quality Scores
Piotroski F5.6
Altman Z10.45
IS Quality66.8
IS Overall60.4
IS Value43.6
Median P/E-5.1
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 246 | 99.9% | -12.9 |
| Other | 11 | 0.1% | — |
Smart Money Overlap
4 holdings with signals
Showing 50 of 257 holdings
· Page 1 of 6
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES INC | GILD | 9.64% | $768.7M | 5,440,729 | 20.0 | $169.9B | Healthcare |
| 2 | VERTEX PHARMACEUTICALS INC | VRTX | 8.95% | $713.1M | 1,578,979 | 29.1 | $115.2B | Healthcare |
| 3 | AMGEN INC | AMGN | 8.74% | $696.6M | 1,981,880 | 24.7 | $190.4B | Healthcare |
| 4 | REGENERON PHARMACEUTICALS INC | REGN | 6.91% | $550.6M | 739,990 | 17.3 | $78.6B | Healthcare |
| 5 | ALNYLAM PHARMACEUTICALS INC | ALNY | 3.75% | $298.7M | 948,943 | 138.3 | $43.5B | Healthcare |
| 6 | INSMED INC | INSM | 2.75% | $219.5M | 1,537,964 | -24.7 | $31.8B | Healthcare |
| 7 | ARGENX SE ADR | ARGX | 2.54% | $202.7M | 295,987 | 37.7 | $42.9B | Healthcare |
| 8 | BIOGEN INC | BIIB | 2.45% | $195.2M | 1,070,971 | 21.7 | $28.0B | Healthcare |
| 9 | NATERA INC | NTRA | 2.38% | $190.0M | 960,478 | -128.8 | $27.8B | Healthcare |
| 10 | UNITED THERAPEUTICS CORP | UTHR | 2.02% | $161.1M | 303,753 | 17.7 | $23.3B | Healthcare |
| 11 | BEONE MEDICINES AG | ONC | 1.87% | $149.3M | 528,778 | 156.6 | $29.6B | Healthcare |
| 12 | ILLUMINA INC | ILMN | 1.68% | $133.5M | 1,086,089 | 22.4 | $19.0B | Healthcare |
| 13 | MODERNA INC | MRNA | 1.67% | $132.8M | 2,534,609 | -7.4 | $21.2B | Healthcare |
| 14 | INCYTE CORP | INCY | 1.64% | $131.0M | 1,420,076 | 14.2 | $18.4B | Healthcare |
| 15 | REVOLUTION MEDICINES INC | RVMD | 1.49% | $118.6M | 1,208,856 | -15.7 | $18.5B | Healthcare |
| 16 | GENMAB SPONSORED ADR | GMAB | 1.17% | $93.0M | 3,595,754 | 25.7 | $16.1B | Healthcare |
| 17 | NEUROCRINE BIOSCIENCES INC | NBIX | 1.16% | $92.8M | 709,918 | 27.5 | $13.3B | Healthcare |
| 18 | ROIVANT SCIENCES LTD | ROIV | 1.10% | $88.0M | 3,164,494 | -23.6 | $19.6B | Healthcare |
| 19 | BRIDGEBIO PHARMA INC | BBIO | 1.06% | $84.4M | 1,203,278 | -19.6 | $14.1B | Healthcare |
| 20 | IONIS PHARMACEUTICALS INC | IONS | 1.04% | $83.3M | 1,161,634 | -31.6 | $12.3B | Healthcare |
| 21 | EXELIXIS INC | EXEL | 0.98% | $78.3M | 1,898,857 | 14.7 | $11.4B | Healthcare |
| 22 | ASCENDIS PHARMA ADR REPRESENTING | ASND | 0.97% | $77.0M | 338,791 | -51.6 | $13.5B | Healthcare |
| 23 | BIOMARIN PHARMACEUTICAL INC | BMRN | 0.96% | $76.7M | 1,384,339 | 30.5 | $10.7B | Healthcare |
| 24 | MEDPACE HOLDINGS INC | MEDP | 0.94% | $75.2M | 165,248 | 29.3 | $13.2B | Healthcare |
| 25 | MADRIGAL PHARMACEUTICALS INC | MDGL | 0.84% | $66.7M | 150,846 | -40.4 | $11.9B | Healthcare |
| 26 | BIO TECHNE CORP | TECH | 0.72% | $57.2M | 1,125,877 | 101.3 | $8.2B | Healthcare |
| 27 | CHARLES RIVER LABORATORIES INTERNA | CRL | 0.70% | $55.9M | 355,726 | -56.3 | $8.1B | Healthcare |
| 28 | CYTOKINETICS INC | CYTK | 0.68% | $54.5M | 876,719 | -9.9 | $7.8B | Healthcare |
| 29 | HALOZYME THERAPEUTICS INC | HALO | 0.68% | $54.1M | 850,231 | 23.5 | $7.5B | Healthcare |
| 30 | PRAXIS PRECISION MEDICINES INC | PRAX | 0.68% | $53.9M | 186,539 | -22.5 | $6.4B | Healthcare |
| 31 | ARROWHEAD PHARMACEUTICALS INC | ARWR | 0.66% | $52.3M | 921,500 | 42.1 | $8.5B | Healthcare |
| 32 | VAXCYTE INC | PCVX | 0.63% | $50.4M | 928,371 | -9.7 | $7.9B | Healthcare |
| 33 | AXSOME THERAPEUTICS INC | AXSM | 0.60% | $47.8M | 302,790 | -45.4 | $8.4B | Healthcare |
| 34 | ABIVAX AMERICAN DEPOSITARY SHARES | ABVX | 0.60% | $47.7M | 384,974 | -30.8 | $7.2B | Healthcare |
| 35 | BIONTECH SE ADR | BNTX | 0.57% | $45.2M | 502,347 | -16.3 | $22.0B | Healthcare |
| 36 | REPLIGEN CORP | RGEN | 0.57% | $45.8M | 389,358 | 132.3 | $6.4B | Healthcare |
| 37 | KRYSTAL BIOTECH INC | KRYS | 0.57% | $45.6M | 181,965 | 35.5 | $7.3B | Healthcare |
| 38 | PROTAGONIST THERAPEUTICS INC | PTGX | 0.53% | $42.0M | 432,386 | -49.9 | $6.5B | Healthcare |
| 39 | RHYTHM PHARMACEUTICALS INC | RYTM | 0.49% | $39.2M | 456,161 | -27.9 | $5.6B | Healthcare |
| 40 | PTC THERAPEUTICS INC | PTCT | 0.47% | $37.8M | 563,587 | 7.9 | $5.5B | Healthcare |
| 41 | ARCELLX INC | ACLX | 0.45% | $36.2M | 316,556 | -28.2 | $6.7B | Healthcare |
| 42 | TEMPUS AI INC CLASS A | TEM | 0.45% | $36.3M | 744,845 | -32.4 | $7.9B | Healthcare |
| 43 | MIRUM PHARMACEUTICALS INC | MIRM | 0.44% | $35.1M | 382,893 | -191.0 | $4.5B | Healthcare |
| 44 | NUVALENT INC CLASS A | NUVL | 0.43% | $34.1M | 349,618 | -17.3 | $7.2B | Healthcare |
| 45 | KYMERA THERAPEUTICS INC | KYMR | 0.43% | $34.4M | 435,136 | -21.7 | $6.5B | Healthcare |
| 46 | AMICUS THERAPEUTICS INC | FOLD | 0.40% | $31.8M | 2,212,558 | -164.5 | $4.5B | Healthcare |
| 47 | ALKERMES | ALKS | 0.40% | $32.1M | 1,181,876 | 20.4 | $5.0B | Healthcare |
| 48 | CRISPR THERAPEUTICS AG | CRSP | 0.40% | $31.9M | 668,483 | -7.4 | $4.6B | Healthcare |
| 49 | TERNS PHARMACEUTICALS INC | TERN | 0.39% | $31.4M | 658,188 | -51.6 | $4.8B | Healthcare |
| 50 | COGENT BIOSCIENCES INC | COGT | 0.39% | $30.9M | 899,803 | -7.6 | $6.0B | Healthcare |